AFT Pharmaceuticals Limited (NZE:AFT)
New Zealand · Delayed Price · Currency is NZD 2.820
+0.040 (1.44%)
Sep 29, 2025, 3:47 PM NZST
AFT Pharmaceuticals Company Description
AFT Pharmaceuticals Limited, together with its subsidiaries, develops, markets, and distributes pharmaceutical products in New Zealand, Australia, Asia, and internationally.
The company offers patented, branded, and generic drugs; and products for use in the areas of allergy, cold and flu, digestive health, eye care, first aid, pain management, skin care, vitamins, supplements, gastrointestinal, dermatology, and hospital.
It has a research and development collaboration with Belgium’s Hyloris Pharmaceuticals to develop a novel innovative injectable iron deficiency therapy.
AFT Pharmaceuticals Limited was incorporated in 1997 and is headquartered in Auckland, New Zealand.
AFT Pharmaceuticals Limited
| Country | New Zealand |
| Founded | 1997 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 119 |
| CEO | Hartley Atkinson |
Contact Details
Address: 129 Hurstmere Road Auckland, 0622 New Zealand | |
| Phone | 64 8 0042 3823 |
| Website | aftpharm.com |
Stock Details
| Ticker Symbol | AFT |
| Exchange | New Zealand Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | NZD |
| ISIN Number | NZAFTE0001S4 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Hartley Atkinson | Chief Executive Officer |
| Malcolm Tubby | Chief Financial Officer |